Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30831714 | 0.94 | CYP1A2 (0.42) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL8851453 | 0.88 | CYP1A2 (0.37) | CYP1A2CHRM2CYP2D6CHRM1KCNH2 | |
| SCHEMBL27895146 | 0.87 | CYP1A2 (0.50) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL8850757 | 0.85 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL8850867 | 0.79 | CYP1A2 (0.34) | CYP1A2EPHX1CHRM2CYP2D6CHRM1 | |
| SCHEMBL12314441 | 0.78 | NAAA (0.39) | CYP1A2NAAAEPHX1EPHX2 | |
| SCHEMBL7611041 | 0.78 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL104299 | 0.78 | CYP1A2 (0.45) | CYP1A2CNR1NAAAEPHX1SIGMAR1 | |
| SCHEMBL3971024 | 0.77 | CYP1A2 (0.41) | CYP1A2NAAA | |
| SCHEMBL5606813 | 0.77 | CYP1A2 (0.41) | CYP1A2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015441-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2026-01-15 | — | — | US | disclosed |
| EP-4551618-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | Basell Poliolefine Italia S.r.l. (IT) | 2025-05-14 | — | — | EP | disclosed |
| CN-119317649-A | Catalyst component for olefin polymerization | 巴塞尔聚烯烃意大利有限公司 | 2025-01-14 | — | — | CN | disclosed |
| WO-2024008862-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2024-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015441-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | P4HA1, TCP1, PPT1 | CYP1A2 1648/4885CNR1 1665/4885NAAA 2915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.